Ignite Creation Date:
2025-12-25 @ 12:08 AM
Ignite Modification Date:
2026-04-24 @ 11:27 PM
Study NCT ID:
NCT04990258
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-01-24
First Post:
2021-06-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A 24-month Real Life PErsistence Efficacy and Safety Study in IBD Patients in REMission Switched From Intravenous Infliximab to Subcutaneous Infliximab CT-P13 Remsima®SC
Sponsor:
Organization: